Rohto Pharmaceutical Co.,Ltd.
Rohto Pharmaceutical Co.,Ltd.
Your view on RPHCF
Overview
What the company does, where it operates, and who runs it.
About Rohto Pharmaceutical Co.,Ltd.
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
- CEO
- Hidetoshi Segi
- Headquarters
- 1-8-1, Tatsumi-nishi, Osaka, JP
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
- CEO
- Hidetoshi Segi
- Headquarters
- 1-8-1, Tatsumi-nishi, Osaka, JP
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.
Infographics
Visual summary of the business at a glance.
Media
Videos and interviews covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Comparables
List of peer companies in the same industry.
Institutional Ownership
Which funds and firms own the stock.
Insider Trading
Recent buying and selling by company executives.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
News
Latest headlines and market coverage.